Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United States

Yizhen Lai, Arielle G. Bensimon, Emily Gao, Rituparna Bhattacharya, Ruifeng Xu, Jestinah Chevure, Kentaro Imai, Naomi B. HaasClinical 2023 · DOI

BibTeX
@inproceedings{lai2023cost,
  author = {Yizhen Lai and Arielle G. Bensimon and Emily Gao and Rituparna Bhattacharya and Ruifeng Xu and Jestinah Chevure and Kentaro Imai and Naomi B. Haas},
  title = {{Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United States}},
  booktitle = {Clinical},
  year = {2023},
  doi = {10.1016/j.clgc.2023.03.016},
}

Loading related content...

Figure